ASML vs BVS · P/E 57, $665.37B cap vs rev $573.3M
ASML Holding NV ADR (ASML) versus Bioventus Inc (BVS) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Bioventus Inc (BVS) is a medical devices company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. BVS currently screens at market cap $495.1M.
Not investment advice. Open the ASML and BVS stock pages for the full models.
Not investment advice.